Invention Grant
- Patent Title: Purification of HBV antigens for use in vaccines
- Patent Title (中): HBV抗原的纯化用于疫苗
-
Application No.: US12342220Application Date: 2008-12-23
-
Publication No.: US08624004B2Publication Date: 2014-01-07
- Inventor: Koen De-Heyder , Peter Schu , Michelle Serantoni , Omer Van-Opstal
- Applicant: Koen De-Heyder , Peter Schu , Michelle Serantoni , Omer Van-Opstal
- Applicant Address: BE Rixensart
- Assignee: Glaxosmithkline Biologicals, S.A.
- Current Assignee: Glaxosmithkline Biologicals, S.A.
- Current Assignee Address: BE Rixensart
- Agency: Glaxosmithkline Global Patents
- Agent Gwynedd Warren
- Priority: GB0019728.5 20000810; GB0101334.1 20010118
- Main IPC: C12P21/02
- IPC: C12P21/02 ; C12N15/00
Abstract:
The present invention relates to a method for the production of a hepatitis B antigen suitable for use in a vaccine, the method comprising purification of the antigen in the presence of cysteine, to vaccines comprising such antigens.
Public/Granted literature
- US20090123496A1 PURIFICATION OF HBV ANTIGENS FOR USE IN VACCINES Public/Granted day:2009-05-14
Information query
